Risk of fatigue in cancer patients treated with anti programmed cell death-1/anti programmed cell death ligand-1 agents: a systematic review and meta-analysis

Immunotherapy,Volume 10, Issue 15, Page 1303-1313, November 2018.

Source: Immunotherapy - November 26, 2018 Category: Allergy & Immunology Authors: Matteo Santoni Alessandro Conti Sebastiano Buti Melissa Bersanelli Laura Foghini Francesco Piva Matteo Giulietti Lukas Lusuardi Nicola Battelli Source Type: research